share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

SEC ·  Sep 4 05:51

Summary by Futu AI

On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.
On August 31, 2024, CVS Health Corp's EVP and Chief Technology Officer, Mandadi Tilak, completed a sale of 13,097 shares of common stock at a price of $57.24 per share. The transaction, which was carried out under the transaction code 'F' indicating a payment of exercise price or tax liability by delivering or withholding securities, resulted in a total market value of $749,672.28. Following the sale, Tilak's direct holdings in CVS Health Corp amounted to 40,414 shares.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.